(Q50248992)

28 February 2018

title

Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. (English)

1 reference

28 February 2018

0 references

Qiang Zhou

1

1 reference

28 February 2018

Xue-Qiang Zhu

2

1 reference

28 February 2018

Jun Zhang

3

1 reference

28 February 2018

Zhong-Lin Xu

4

1 reference

28 February 2018

Pei Lu

5

1 reference

28 February 2018

Feng Wu

6

1 reference

28 February 2018

publication date

14 September 2007

1 reference

28 February 2018

Ultrasound in Medicine and Biology

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 February 2018

volume

34

1 reference

28 February 2018

issue

1

1 reference

28 February 2018

page(s)

81-87

1 reference

28 February 2018

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Effect of surgical treatment on the cellular immune response of gastric cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Technology insight: High-intensity focused ultrasound for urologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

The host-tumor immune conflict: from immunosuppression to resistance and destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Abdominal surgical interventions: local and systemic consequences for the immune system--a prospective study on elective gastrointestinal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Where have all the T cells gone? Mechanisms of immune evasion by tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Surgical stress response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

High-intensity focused ultrasound for the treatment of liver tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

High-intensity focused ultrasound in the treatment of solid tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Immature myeloid cells and cancer-associated immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Surgical trauma: hyperinflammation versus immunosuppression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Cytokine secretion: clinical relevance of immunosuppression in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Does the immune system see tumors as foreign or self?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Resection of solid tumors reverses T cell defects and restores protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Antigen-processing machinery breakdown and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

CD4+ CD25+ suppressor T cells: more questions than answers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Immunosuppressive mechanisms in the microenvironment of malignant pleural effusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Chemotherapy-induced immunosuppression and reconstitution of immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Perioperative Immunosuppression in Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Host antitumour immune responses to HIFU ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Tumor-host immune interactions and dendritic cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2007.07.013

10.1016/J.ULTRASMEDBIO.2007.07.013

7 January 2021

Identifiers

DOI

1 reference

28 February 2018

1 reference

28 February 2018